The burden of infectious diseases throughout and after the COVID‐19 pandemic (2020–2023) and Russo‐Ukrainian war migration
Journal of Medical Virology,
Год журнала:
2024,
Номер
96(5)
Опубликована: Май 1, 2024
Understanding
how
the
infectious
disease
burden
was
affected
throughout
COVID-19
pandemic
is
pivotal
to
identifying
potential
hot
spots
and
guiding
future
mitigation
measures.
Therefore,
our
study
aimed
analyze
changes
in
rate
of
new
cases
Poland's
most
frequent
diseases
during
entire
after
influx
war
refugees
from
Ukraine.
We
performed
a
registry-based
population-wide
Poland
24
2020
2023
compared
them
prepandemic
period
(2016-2019).
Data
were
collected
publicly
archived
datasets
Epimeld
database
published
by
national
epidemiological
authority
institutions.
The
studied
(66.6%)
revealed
significantly
negative
correlations
with
SARS-CoV-2
infections.
For
majority
diseases,
it
substantially
decreased
(in
case
83%)
2021
(63%),
following
which
mostly
rebounded
levels
and,
some
cases,
exceeded
when
exceptionally
high
annual
rates
scarlet
fever,
Streptococcus
pneumoniae
infections,
HIV
syphilis,
gonococcal
tick-borne
encephalitis
noted.
Clostridioides
difficile
enterocolitis
two-fold
higher
than
before
onward.
Legionnaires'
also
threshold,
although
this
due
local
outbreak
unrelated
lifted
restrictions
or
migration
refugees.
migrants
Ukraine
could
impact
epidemiology
sexually
transmitted
diseases.
present
analysis
indicates
that
continued
efforts
are
needed
prevent
overwhelming
healthcare
systems
again
decreasing
control
over
other
It
identifies
tipping
points
require
additional
measures,
discussed
paper,
avoid
escalation
future.
Язык: Английский
Ongoing outbreak of maternal parvovirus B19 infections in Germany since end of 2023: consequence of COVID‐19 pandemic?
Ultrasound in Obstetrics and Gynecology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 6, 2025
To
investigate
the
ongoing
parvovirus
B19
(B19V)
outbreak
among
pregnant
women
in
Germany
and
its
connection
to
coronavirus
disease
2019
(COVID-19)
pandemic.
This
retrospective
cohort
study
analyzed
anonymous
data
regarding
serologically
confirmed
B19V
infections
during
pregnancy
between
January
2014
April
2024
across
13
major
fetal
medicine
centers
Germany.
We
evaluated
yearly
frequency
of
cases,
cases
that
underwent
intrauterine
transfusion
(IUT),
presenting
with
hydrops
fetalis
death
(IUFD)
related
infection,
stratified
these
variables
by
event
occurrence
<
20
weeks'
gestation
or
≥
gestation.
Variables
were
compared
three
subperiods:
pre
COVID-19
pandemic,
pandemic
post
Data
from
918
infection
revealed
a
significant
since
end
2023.
The
mean
±
SD
number
annual
was
57.3
20.7
COVID-19,
20.3
13.5
surged
384.8
299.8
(P
0.01).
Correspondingly,
which
fetus
IUT
increased
COVID-19.
proportion
diagnoses
made
before
32.3%
53.2%
0.001).
These
results
demonstrate
an
unforeseen
increase
after
consequent
rise
anemia.
introduced
policies
reduced
rate
but
likely
conditioned
present
upsurge.
Counseling,
early
detection
access
specialized
performing
are
essential
measures
required
address
this
outbreak.
©
2025
Author(s).
Ultrasound
Obstetrics
&
Gynecology
published
John
Wiley
Sons
Ltd
on
behalf
International
Society
Gynecology.
Язык: Английский
Current Massive Parvovirus B19 Outbreak in Germany and the Risk of Intrauterine Infection. A Consequence of the Covid-19 Pandemic?
Опубликована: Янв. 1, 2024
Язык: Английский
Unveiling the Burden of Hepatitis A in Salerno, Italy: A Comprehensive 9-Year Retrospective Study (2015–2023) on the Seroprevalence of HAV Antibodies and Age/Sex Distribution
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(18), С. 5534 - 5534
Опубликована: Сен. 18, 2024
Background:
Hepatitis
A
virus
(HAV)
infection
is
a
significant
global
cause
of
viral
hepatitis.
At
present,
the
anti-HAV
vaccine
in
Italy
proposed
exclusively
for
specific
high-risk
groups,
and
universal
vaccination
program
not
implemented.
Objectives:
This
study
aimed
to
assess
level
immunity
against
HAV
patients
both
sexes
across
age
groups
ranging
from
0
95
years
admitted
San
Giovanni
di
Dio
e
Ruggi
d’Aragona
Hospital
Salerno,
Italy,
over
9-year
period
(2015–2023).
Methods:
The
total
seroprevalence
by
chemiluminescence
Vitros
system
immunodiagnostics
(ortho-diagnostics)
was
obtained
database
analysis,
stratifying
gender
group
pre-pandemic
(2015–2019)
pandemic
(2020–2023)
periods.
Results:
Out
28,104
samples
collected
2015–2023,
20,613
resulted
positive
immune
screening,
with
reduction
annualized
proportion
events
during
compared
period.
more
abundant
males
than
females
periods
(exceeding
70%),
statistically
decrease
2015–2019.
61–70-year-old
susceptible
genders,
strong
deviation
41–50-year-old
51–60-year-old
group.
affected
number
analyzed
2020.
Conclusions:
revealed
high
seroprevalence,
especially
individuals
aged
61–70
years.
There
notable
These
results
emphasize
need
ongoing
monitoring
suggest
that
could
address
regional
gaps
lower
disease
incidence.
Язык: Английский
OUTBREAK OF VIRAL HEPATITIS A IN VINNITSYA REGION IN WARTIME PERIOD AMONG PEDIATRIC POPULATION: CLINICAL AND LABORATORY FEATURES
Clinical and Preventive Medicine,
Год журнала:
2024,
Номер
7, С. 6 - 12
Опубликована: Ноя. 28, 2024
Introduction.
HAV
is
a
ubiquitous
viral
disease
with
faecal-oral
transmission
mechanism,
characterized
by
liver
lesions.
According
to
global
data
reposts,
the
frequency
of
outbreaks
all
over
world
had
increased.
From
beginning
outbreak
(Vinnytsia,
Ukraine)
in
2023
incidence
rate
was
detected
as
27,25
per
100,000
(in
2022—0,35
100,000).
Having
analyzed
these
data,
also
were
registered
among
pediatric
population
(88
out
454
cases
during
outbreak;
19,3%).
Incidence
and
evidence
rates
increased,
especially
regions
increased
military
activities,
also,
facts
shown
increasing
role
on
burden
public
health
system.
Aim.
To
estimate
peculiarities
clinical,
laboratory
features,
genotype
distribution
patients
Vinnitsya
region
2023–2024
years.
Materials
methods.
Among
88
outbreak,
31
children
examined
course
study
formed
group
(boys—51,6%;
average
age—12,84±0,16
years).
Clinical
examination
patients,
instrumental
assays,
ELISA,
PCR-testing
performed
accordance
standard
management.
All
(n=31;
100%)
confirmed
ELISA
additionally
for
16,1%
(n=5)
examined.
Statistical
analysis
using
«SPSS
v.22.0».
The
considered
significant
at
p<0.05.
Results.
During
HAV,
46
serum
samples
tested
PCR
genome
sequencing
78,2%
(n=36)
IB
while
21,8%
(n=10)
–
IA
genotype.
(n=5),
80%
(n=4)
tested,
IA—in
20%
(n=1).
severe
100%
(n=31)
according
indexes.
Frequency
clinical
symptoms
group.
level
total
bilirubin,
ALT,
AST
estimated
significance.
Severe
could
be
explained
spreading
outbreak.
Conclusions.
associated
HAV.
paediatric
80%.
main
parameters.
Язык: Английский